Anti-Alzheimer’s Disease activity: In vitro AChE inhibitory activity3: IC50 = 2.06 ± 0.04 μg/mLDonepezil HCI (positive control): IC50 = 0.03 ± 0.00 μg/mL. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.